External broker reports(aggregated public sources), Ord Minnett

Ord Minnett

Ord Minnett is a leading Australian wealth management group, incorporating full-service stockbroking, financial planning and funds management. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>We initiate coverage of 4DMedical (4DX) with a $1.20 price target and a Speculative Buy recommendation.</li><li>4DX is a global medical technology company focused on the commercialisation of its flagship respiratory imaging platform, XV Technology.</li><li>We believe the company is strongly positioned to disrupt the US$31b global respiratory diagnostics market, with its software products offering a step-change in diagnostic capability vs incumbent modalities (e.g. chest X-rays, CTs). </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We initiate coverage of 4DMedical (4DX) with a $1.20 price target and a Speculative Buy recommendation.4DX is a global medical technology company focused on the commercialisation of its flagship respiratory imaging platform, XV Technology.We believe the company is strongly positioned to disrupt the US$31b global respiratory diagnostics market, with its software products offering a step-change in diagnostic capability vs incumbent modalities (e.g. chest X-rays, CTs). Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

4DMedical

4DMedical Limited - Owning the Lung